Our study, in 1002 breast cancer patients using routine histology sections stained with H&E, reveals that colocalization of cancer cells and immune cells is a significant indicator of favorable survival, independent of and stronger than standard clinical variables, particularly in Her2+ breast cancer. The gene discussed is ERBB2; the disease is cancer.